Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential

STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential
ShareXFacebook

Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

The Case Against Calling It 'Emergency Medicine'
MedPage Today

The Case Against Calling It 'Emergency Medicine'

(MedPage Today) -- Names matter. They shape expectations, guide behavior, and in medicine, determine how systems are built, how resources are allocated, and how clinicians practice. The name "emergency medicine" is one of the most consequential...

Read more →
Advertisement